Sort   by:  
 Page size 
UnknownSingle-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival.
Not available
S-EPMC7847307 | biostudies-literature
UnknownHigh-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma.
Not available
S-EPMC6673710 | biostudies-literature
UnknownGLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.
Not available
S-EPMC7442809 | biostudies-literature
UnknownPRMT5 inhibition disrupts splicing and stemness in glioblastoma.
Not available
S-EPMC7881162 | biostudies-literature
UnknownFunctional Enhancers Shape Extrachromosomal Oncogene Amplifications.
Not available
S-EPMC7241652 | biostudies-literature
UnknownMetabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
Not available
S-EPMC10782558 | biostudies-literature
UnknownIntegrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Not available
S-EPMC5500911 | biostudies-literature
UnknownEpigenomic alterations define lethal CIMP-positive ependymomas of infancy.
Not available
S-EPMC4174313 | biostudies-literature
UnknownTherapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
Not available
S-EPMC5993422 | biostudies-literature
UnknownZIC1 is a context-dependent medulloblastoma driver in the rhombic lip.
Not available
S-EPMC11735403 | biostudies-literature
Sort   by:  
 Page size